
Sign up to save your podcasts
Or
At the start of 2020, Barry Wark and the team at Ovation.io were on a growth path – not even they could envision 75x usage growth they ended up seeing. Madrona investor, Chris Picardo, talks to Barry about the year and how the incredible amount of genomic data created by COVID testing will be a tailwind to academics, researchers and others looking for treatment and cures for disease.
4.8
1212 ratings
At the start of 2020, Barry Wark and the team at Ovation.io were on a growth path – not even they could envision 75x usage growth they ended up seeing. Madrona investor, Chris Picardo, talks to Barry about the year and how the incredible amount of genomic data created by COVID testing will be a tailwind to academics, researchers and others looking for treatment and cures for disease.
1,007 Listeners
509 Listeners
1,847 Listeners
321 Listeners
344 Listeners
210 Listeners
188 Listeners
8,765 Listeners
350 Listeners
142 Listeners
128 Listeners
72 Listeners
428 Listeners
438 Listeners
37 Listeners